Investors don’t care how fancy your tech is.Diego is the CEO of Qnity, a pharmatech startup that uses quantum electrochemistry to develop devices for drug discovery and screening. In this episode, we discuss his lessons as a second-time founder and his insights on fundraising in the deeptech space.Topics in this episode0:00 Intro1:26 How Was Qnity Founded?3:58 What Is Krilltech?7:39 What Is Smart Money?9:12 How to Talk About Deeptech to Investors16:27 How to Build a Product Roadmap22:49 Creating Interest and Managing Investor Objections28:15 Advice for Deeptech Founders31:31 Partnering with Oxford University34:45 Marketing Strategies for Deeptech Startups38:51 Understanding the Drug Discovery Market41:37 Inside Qnity's Fundraising Journey44:15 Expanding the Team45:27 Fundraising Milestones for a Seed Round48:22 Challenges in Building Client Relationships50:08 How to Find the Right Capital for Your Startup51:55 The Most Important Trait of a Deeptech Founder57:29 What's Next for Qnity?Connect with Diego on LinkedIn https://www.linkedin.com/in/diegostoneaires/?originalSubdomain=brFollow Qnity on LinkedIn https://www.linkedin.com/company/qnity/posts/?feedView=all Visit Qnity’s Website http://qnity.bio/ Connect with JP Orlov on LinkedIn https://www.linkedin.com/in/jp-orlov/Follow Science VC on LinkedIn https://www.linkedin.com/company/science-vcFollow Science VC on Instagram https://www.instagram.com/science.vcSubscribe to Science VC on YouTube https://www.youtube.com/@ScienceVCSubscribe to our Newsletter https://substack.com/@jporlovLearn how WeArePalta can help your deeptech company communicate its science and impact https://www.wearepalta.com/

Ver todos los episodios